# Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery

> **NCT01988246** · PHASE1,PHASE2 · COMPLETED · sponsor: **Rishi Singh** · enrollment: 30 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Aflibercept
- **DRUG:** Sham

## Key facts

- **NCT ID:** NCT01988246
- **Lead sponsor:** Rishi Singh
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2018-04-25
- **Final completion:** 2020-01-14
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01988246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01988246, "Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01988246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*